» Articles » PMID: 1125521

Observations on the Dose Regime of Fluphenazine Decanoate in Maintenance Therapy Ofschizophrenia

Overview
Journal Br J Psychiatry
Specialty Psychiatry
Date 1975 May 1
PMID 1125521
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

An analysis of the drug regimes prescribed to two separate groups of unselected schizophrenic patients indicates certain trends of clinical importance. The results demonstrate a need for the adoption of a personalized dose regime. The scatter of dose regimes found effective is too great to recommend a standardized approach to the prescription of L.A.P. injections. Two other results of particular significance are that the dose of drug required to control symptoms can be gradually reduced in nearly half of patients,and that helpful trends in prescribing were identified that will help the clinician to abolish side-effects.

Citing Articles

Clinically significant interactions of psychotropic agents with antipsychotic drugs.

Meyer M, Baldessarini R, Goff D, Centorrino F Drug Saf. 1996; 15(5):333-46.

PMID: 8941495 DOI: 10.2165/00002018-199615050-00004.


Review: treatment of schizophrenia. State of the art.

Moller H Eur Arch Psychiatry Clin Neurosci. 1996; 246(5):229-34.

PMID: 8863000 DOI: 10.1007/BF02190273.


Pharmacological treatment of patients with schizophrenia. Past and present problems and potential future therapy.

Johnson D Drugs. 1990; 39(4):481-8.

PMID: 2190791 DOI: 10.2165/00003495-199039040-00001.


Assessment of drugs in schizophrenia. Diagnosis and patient selection.

Forrest A Br J Clin Pharmacol. 1976; 3(3 Suppl 2):367-70.

PMID: 791323 PMC: 1428825. DOI: 10.1111/j.1365-2125.1976.tb03726.x.


Treatment of chronic schizophrenia.

Johnson D Drugs. 1977; 14(4):291-9.

PMID: 21070 DOI: 10.2165/00003495-197714040-00004.